- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00202215
Chrysalis Day Program Body Mass Index Study
A Study on the Effects of a Personality Disorder Day Hospital Program on Clients Body Mass Index
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As part of the Providence Continuing Care Center's continuing quality improvement initiatives this study is to more systematically evaluate the success of the Chrysalis Day Hospital Program in dealing with some features of eating disorders commonly experienced by its patients.
At intake all clients will be approached to give informed consent to participate. If they do consent they will have their height and weight recorded( if they request they will not be told their weight)as part of the usual intake process conducted by a dietician.
When clients exit the program they again will be approached to be weighed. The body mass index will be calculated and compared to admission values.
The Chrysalis Program is a unique day hospital approach to treating individuals with severe personality disorders (primarily Borderline)that views the eating disordered behaviour common to these clients as a symptom of many and by addressing core issues of affect dysregulation as well as psychoeducation about eating the eating problems will improve .
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 4X3
- Providence Care Centre Mental Health Services
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- clients of the Chrysalis Program
Exclusion Criteria:
- clients of the Chrysalis Program who do not consent to the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Body Mass Index at time of enrolling in programme and at leaving
Time Frame: at entry and upon leaving the program
|
at entry and upon leaving the program
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
patient demographics relationship to outcome
Time Frame: upon entry and exit from the program
|
upon entry and exit from the program
|
|
programme changes and relation to outcome
Time Frame: from start to the end of the study
|
from start to the end of the study
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stephen H McNevin, MD, Queens University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PDS002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.